These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 19479860

  • 1. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 3. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Nov; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 4. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 5. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 6. In vivo and in vitro production of anti-histone antibodies in NZB/NZW mice.
    Gioud M, Kotzin BL, Rubin RL, Joslin FG, Tan EM.
    J Immunol; 1983 Jul; 131(1):269-74. PubMed ID: 6863918
    [Abstract] [Full Text] [Related]

  • 7. Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.
    Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW.
    Arthritis Rheum; 2005 Feb; 52(2):642-50. PubMed ID: 15692982
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
    Wang X, Huang W, Schiffer LE, Mihara M, Akkerman A, Hiromatsu K, Davidson A.
    Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
    [Abstract] [Full Text] [Related]

  • 10. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
    Maeda T, Nomoto K.
    J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
    [Abstract] [Full Text] [Related]

  • 11. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 12. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A.
    Int Immunol; 2004 Jul 15; 16(7):937-46. PubMed ID: 15148287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B, Wu J, Chu YW, Wang Y, Wang DP, Wu HS, Xiong SD.
    Rheumatology (Oxford); 2005 Sep 15; 44(9):1108-14. PubMed ID: 15840592
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA.
    Genes Immun; 2008 Mar 15; 9(2):137-52. PubMed ID: 18200028
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice.
    Hentati B, Sato MN, Payelle-Brogard B, Avrameas S, Ternynck T.
    Eur J Immunol; 1994 Jan 15; 24(1):8-15. PubMed ID: 8020574
    [Abstract] [Full Text] [Related]

  • 18. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F, Gambini C, Gregorio A, Mosconi M, Reverberi D, Gattorno M, Casazza S, Uccelli A, Moretta L, Martini A, Traggiai E.
    Arthritis Rheum; 2010 Sep 15; 62(9):2776-86. PubMed ID: 20496367
    [Abstract] [Full Text] [Related]

  • 19. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
    Hayashi T, Hasegawa K, Sasaki Y, Mori T, Adachi C, Maeda K.
    Nephrol Dial Transplant; 2007 Nov 15; 22(11):3131-8. PubMed ID: 17670770
    [Abstract] [Full Text] [Related]

  • 20. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
    Dong L, Ito S, Ishii KJ, Klinman DM.
    Arthritis Rheum; 2005 Feb 15; 52(2):651-8. PubMed ID: 15692999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.